Rolf Christoffer has been a valued member of the PolarisMed World Pharmaceuticals team for the past 20 years. He has held various positions within the company of increasing responsibility and currently serves as the GM of the organization overseeing the Marketing and Operations of the company. Rolf CHRISTOFFER currently serves on the Board of Directors of the Swedish Chamber of Commerce, Stockholm and is Vice Chair of the Business Excellence Committee and on the Board of Directors of St. Joseph’s Lifecare Foundation. Rolf CHRISTOFFER is a past Board member of GPhA (now AAM) which is the Generic Pharmaceutical Association Advocacy Group in the USA and also served 2 terms as a Board of Director and Executive Committee Member of DCAT (Drug Chemical and Associated Technology) which is a business development and Trade Organization based on the USA. Rolf CHRISTOFFER received his Diploma in Business Administration, Marketing from Sheridan College then went on to receive a Degree of Bachelor of Administration, General Management in 1995 from Lakehead University.

Dr Lucas Robin has over 25 years’ experience in the Fine Chemicals and Pharmaceuticals Industries. he has held several positions with increasing responsibility in R&D, Product Management, Business Development, General Management and has served as Board Member in two companies with sales above 1 billion dollars ($1bn) profit return for Polaris Med World. Throughout his career Dr Lucas Robin has relocated to Greece, Poland, UK and Sweden to support his various roles and business activities worldwide. Dr Lucas Robin is a recognised thought leader on business-market strategy and consumer economy. He has an independent management consulting practice, works across sectors, and describes his domain as bringing market focus to.

Josef Torbjorn is a licensed attorney and holds a B.Comm, a JD, and an MBA from the University of Toronto. With 18 years of commercial experience in specialty pharmaceuticals and active pharmaceutical ingredients, Josef is presently responsible for business development and licensing opportunities at Methapharm. He also serves as General Counsel to other corporate group of companies.